The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe in the treatment of Hyperlipidemia Patients

• Phase: Phase 3

Details

• Lead Sponsor: China Medical University Hospital

Criteria

Inclusion Criteria:

• Patient aged 20-65 years;either sex

• Patient diagnosed with hyperlipidemia(fasting levels of TC>=200mg/dL),or TG>=200mg/dL but <400mg/dL,or LDL-C>=130mg/dL)

• Patient who has signed the informed consent form

Exclusion Criteria:

• Patient with pregnancy (or child bearing potential),or in lactation

• Patient with any lipid regulating agents within 4 weeks prior to study period

• Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, β-blockers, cyclosporins, itraconazole erythromycin,and danazol)

• Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis.

• Patient with liver dysfunction (SGOT or SGPT>2x ULN)

• Patient with renal insufficiency (serum creatinine>1.3mg/dL)

• Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.